The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
暂无分享,去创建一个
J. Buitelaar | T. Banaschewski | D. Brandeis | E. Simonoff | E. Sonuga-Barke | C. Hollis | P. Asherson | H. Steinhausen | S. Cortese | M. Ferrín | D. Daley | R. Dittmann | M. Holtmann | A. Zuddas | D. Coghill | M. Danckaerts | S. van der Oord | C. Soutullo | M. Doepfner | Santosh Paramala | I. Wong
[1] R. Gibbons,et al. Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents. , 2020, Journal of the American Academy of Child and Adolescent Psychiatry.
[2] Yi Hui Liu,et al. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. , 2020, Journal of developmental and behavioral pediatrics : JDBP.
[3] S. Faraone,et al. A literature review and meta-analysis on the effects of ADHD medications on functional outcomes. , 2020, Journal of psychiatric research.
[4] T. Banaschewski,et al. Individualised stepwise adaptive treatment for 3–6-year-old preschool children impaired by attention-deficit/hyperactivity disorder (ESCApreschool): study protocol of an adaptive intervention study including two randomised controlled trials within the consortium ESCAlife , 2020, Trials.
[5] P. Tymms,et al. Academic Outcomes Following a School-Based RCT for ADHD: 6-Year Follow-Up , 2020, Journal of attention disorders.
[6] B. D’Onofrio,et al. Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders. , 2019, Journal of child psychology and psychiatry, and allied disciplines.
[7] Christoph U. Lehmann,et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 2019, Pediatrics.
[8] D. Coghill. Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (For). , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.
[9] B. D’Onofrio,et al. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases , 2019, Biological Psychiatry.
[10] Greta M. Massetti,et al. Randomized Trial of First-Line Behavioral Intervention to Reduce Need for Medication in Children with ADHD , 2019, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.
[11] C. Freitag,et al. Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial , 2019, European Child & Adolescent Psychiatry.
[12] T. Ford,et al. Transition between child and adult services for young people with attention-deficit hyperactivity disorder (ADHD): findings from a British national surveillance study , 2019, The British Journal of Psychiatry.
[13] J. Buitelaar,et al. Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trials. , 2019, The lancet. Psychiatry.
[14] J. Buitelaar,et al. Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study. , 2019, The American journal of psychiatry.
[15] A. Cipriani,et al. Combining Pharmacological and Nonpharmacological Interventions in Network Meta-analysis in Psychiatry. , 2019, JAMA psychiatry.
[16] W. van den Brink,et al. Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial. , 2019, Drug and alcohol dependence.
[17] H. Steinhausen,et al. Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence and the Risk of Crime in Young Adulthood in a Danish Nationwide Study. , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.
[18] Catarina Almqvist,et al. Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication. , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.
[19] C. Hartman,et al. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis , 2019, European Psychiatry.
[20] Frances L. Doyle,et al. A national child mental health literacy initiative is needed to reduce childhood mental health disorders , 2019, The Australian and New Zealand journal of psychiatry.
[21] M. Akmatov,et al. Trends and regional variations in the administrative prevalence of attention-deficit/hyperactivity disorder among children and adolescents in Germany , 2018, Scientific Reports.
[22] C. Flückiger,et al. Adverse effects of psychotherapy: protocol for a systematic review and meta-analysis , 2018, Systematic Reviews.
[23] S. Faraone,et al. Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study. , 2018, The lancet. Psychiatry.
[24] F. Shokraneh,et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis , 2018, The lancet. Psychiatry.
[25] Sally Hopewell,et al. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension , 2018, Trials.
[26] J. Swanson,et al. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment , 2018, Molecular Psychiatry.
[27] Alan E Kazdin,et al. Annual Research Review: Expanding mental health services through novel models of intervention delivery. , 2018, Journal of child psychology and psychiatry, and allied disciplines.
[28] A. Thapar,et al. Conduct disorder in ADHD , 2018, Oxford Medicine Online.
[29] D. Coghill,et al. Quality of life and impairment in ADHD , 2018, Oxford Medicine Online.
[30] D. Coghill,et al. Organizing and delivering treatment for ADHD , 2018, Oxford Medicine Online.
[31] S. Hinshaw,et al. ADHD in the twenty-first century , 2018, Oxford Medicine Online.
[32] J. Biederman,et al. ADHD and substance misuse , 2018, Oxford Medicine Online.
[33] E. Simonoff. Intellectual impairment and neurogenetic disorders , 2018, Oxford Medicine Online.
[34] A. Fallgatter,et al. ESCAlate – Adaptive treatment approach for adolescents and adults with ADHD: study protocol for a randomized controlled trial , 2018, Trials.
[35] E. Luis,et al. Risk of poisoning in children and adolescents with ADHD: a systematic review and meta-analysis , 2018, Scientific Reports.
[36] M. Danckaerts,et al. Oxford Textbook of Attention Deficit Hyperactivity Disorder , 2018, Oxford Medicine Online.
[37] T. Banaschewski,et al. Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)—Study protocol of a randomised controlled trial within the consortium ESCAlife , 2018, Trials.
[38] A. Chacko,et al. Bending the Curve: A Community-Based Behavioral Parent Training Model to Address ADHD-Related Concerns in the Voluntary Sector in Denmark , 2017, Journal of Abnormal Child Psychology.
[39] A. Chacko,et al. Adverse Events in Behavioral Parent Training for Children with ADHD: An Under-Appreciated Phenomenon , 2018 .
[40] David Coghill,et al. ADHD in children and young people: prevalence, care pathways, and service provision. , 2017, The lancet. Psychiatry.
[41] Kenneth K C Man,et al. Association of Risk of Suicide Attempts With Methylphenidate Treatment , 2017, JAMA psychiatry.
[42] P. Chokka,et al. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach , 2017, BMC Psychiatry.
[43] A. Sjölander,et al. Association Between Medication Use and Performance on Higher Education Entrance Tests in Individuals With Attention-Deficit/Hyperactivity Disorder , 2017, JAMA psychiatry.
[44] T. Banaschewski,et al. ESCAschool study: trial protocol of an adaptive treatment approach for school-age children with ADHD including two randomised trials , 2017, BMC Psychiatry.
[45] S. Dalsgaard,et al. Teenage Parenthood and Birth Rates for Individuals With and Without Attention-Deficit/Hyperactivity Disorder: A Nationwide Cohort Study. , 2017, Journal of the American Academy of Child and Adolescent Psychiatry.
[46] A. Sjölander,et al. ADHD Medication and Substance-Related Problems. , 2017, The American journal of psychiatry.
[47] A. Sjölander,et al. Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes , 2017, JAMA psychiatry.
[48] C. Whittington,et al. Annual Research Review: Digital health interventions for children and young people with mental health problems – a systematic and meta‐review , 2017, Journal of child psychology and psychiatry, and allied disciplines.
[49] C. Freitag,et al. Neurofeedback of Slow Cortical Potentials in Children with Attention-Deficit/Hyperactivity Disorder: A Multicenter Randomized Trial Controlling for Unspecific Effects , 2017, Front. Hum. Neurosci..
[50] L. Rohde,et al. What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder? , 2017, ADHD Attention Deficit and Hyperactivity Disorders.
[51] Alan M. Zaslavsky,et al. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys , 2017, ADHD Attention Deficit and Hyperactivity Disorders.
[52] Jürgen Unützer,et al. A Tipping Point for Measurement-Based Care. , 2017, Psychiatric services.
[53] P. Lichtenstein,et al. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study , 2016, Biological Psychiatry.
[54] E. Sonuga-Barke. Can Medication Effects Be Determined Using National Registry Data? A Cautionary Reflection on Risk of Bias in “Big Data” Analytics , 2016, Biological Psychiatry.
[55] D. Brandeis,et al. The European ADHD Guidelines Group replies. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.
[56] J. Micoulaud-Franchi,et al. Neurofeedback in Attention-Deficit/Hyperactivity Disorder: Efficacy. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.
[57] J. Lubar,et al. Neurofeedback in Attention-Deficit/Hyperactivity Disorder: Evaluation Difficulties. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.
[58] P. Lichtenstein,et al. Association Between Prescription of Major Psychotropic Medications and Violent Reoffending After Prison Release. , 2016, JAMA.
[59] T. Banaschewski,et al. Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system , 2016, Translational psychiatry.
[60] T. Moffitt,et al. Life Span Studies of ADHD—Conceptual Challenges and Predictors of Persistence and Outcome , 2016, Current Psychiatry Reports.
[61] Kristian Thorlund,et al. Use of network meta-analysis in clinical guidelines , 2016, Bulletin of the World Health Organization.
[62] V. Harpin,et al. Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study. , 2016, Journal of child psychology and psychiatry, and allied disciplines.
[63] Jim Stevenson,et al. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.
[64] Inbal Nahum-Shani,et al. Treatment Sequencing for Childhood ADHD: A Multiple-Randomization Study of Adaptive Medication and Behavioral Interventions , 2016, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.
[65] W. Kronenberger,et al. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges , 2016, Neuropsychiatric disease and treatment.
[66] E. Simonsen,et al. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials , 2015, BMJ : British Medical Journal.
[67] D. Coghill,et al. Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway , 2015, Child and Adolescent Psychiatry and Mental Health.
[68] S. Dalsgaard,et al. Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study. , 2015, The lancet. Psychiatry.
[69] Stuart Logan,et al. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research. , 2015, Health technology assessment.
[70] D. Coghill,et al. Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes , 2015, Expert review of clinical pharmacology.
[71] D. Coghill,et al. Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls , 2015, European Child & Adolescent Psychiatry.
[72] R. Mikolajczyk,et al. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study. , 2015, JAMA pediatrics.
[73] K. Myers,et al. Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial. , 2015, Journal of the American Academy of Child and Adolescent Psychiatry.
[74] J. Buitelaar,et al. Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials , 2015, Journal of the American Academy of Child and Adolescent Psychiatry.
[75] D. Moher,et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials , 2015, Systematic Reviews.
[76] Justine Schneider,et al. Practitioner Review: Pathways to care for ADHD – a systematic review of barriers and facilitators , 2015, Journal of child psychology and psychiatry, and allied disciplines.
[77] C. Cunningham,et al. Systematic Review of Patients’ and Parents’ Preferences for ADHD Treatment Options and Processes of Care , 2015, The Patient - Patient-Centered Outcomes Research.
[78] V. Roessner,et al. Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany , 2015, European Child & Adolescent Psychiatry.
[79] Jeffrey M. Halperin,et al. Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Irritability: Results From the Multimodal Treatment Study of Children With ADHD (MTA) , 2015, Journal of the American Academy of Child and Adolescent Psychiatry.
[80] Kenneth K C Man,et al. Methylphenidate and the Risk of Trauma , 2015, Pediatrics.
[81] Jonathan Posner,et al. Using Stimulants to Treat ADHD-Related Emotional Lability , 2014, Current Psychiatry Reports.
[82] Marina Danckaerts,et al. Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.
[83] A. Sjölander,et al. Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study , 2014, BMJ : British Medical Journal.
[84] T. Banaschewski,et al. Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.
[85] J. Buitelaar,et al. Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies. , 2014, Journal of child psychology and psychiatry, and allied disciplines.
[86] S. Young,et al. A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations , 2014, Psychological Medicine.
[87] A. Sjölander,et al. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. , 2014, JAMA psychiatry.
[88] L. Rohde,et al. Prevalence of obesity in attention-deficit/hyperactivity disorder: study protocol for a systematic review and meta-analysis , 2014, BMJ Open.
[89] H. Steinhausen,et al. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample , 2014, European Neuropsychopharmacology.
[90] D. Coghill,et al. The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010) , 2013, Child and Adolescent Psychiatry and Mental Health.
[91] K. Matthews,et al. A longitudinal examination of neuropsychological and clinical functioning in boys with attention deficit hyperactivity disorder (ADHD): improvements in executive functioning do not explain clinical improvement , 2013, Psychological Medicine.
[92] M. Arns,et al. Evidence for efficacy of neurofeedback in ADHD? , 2013, The American journal of psychiatry.
[93] D. Brandeis,et al. Response to Chronis-Tuscano et al. and Arns and Strehl. , 2013, The American journal of psychiatry.
[94] David Coghill,et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. , 2013, The American journal of psychiatry.
[95] J. Buitelaar,et al. Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. , 2013, Journal of child psychology and psychiatry, and allied disciplines.
[96] A. Sjölander,et al. Medication for attention deficit-hyperactivity disorder and criminality. , 2012, The New England journal of medicine.
[97] Sudha R. Raman,et al. Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design , 2012, Injury Prevention.
[98] Ö. Özcan,et al. Paediatric trauma patients and attention deficit hyperactivity disorder: correlation and significance , 2012, Emergency Medicine Journal.
[99] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[100] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[101] E. Taylor,et al. Child and caregiver issues in the treatment of attention deficit–hyperactivity disorder: education, adherence and treatment choice , 2011 .
[102] Michelle E. Kho,et al. AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.
[103] Michael Fitzgerald,et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD , 2010, BMC psychiatry.
[104] Harriet Stewart. Developing Mental Health Services for Children and Adolescents with Learning Disabilities: A Toolkit for Clinicians , 2010 .
[105] S. Pliszka. The MTA at 8. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.
[106] P. Emmelkamp,et al. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. , 2008, Clinical psychology review.
[107] Gordon H Guyatt,et al. GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .
[108] S. Cortese,et al. Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future , 2007, Expert review of neurotherapeutics.
[109] S. Hinshaw. Moderators and mediators of treatment outcome for youth with ADHD: understanding for whom and how interventions work. , 2007, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.
[110] B. Horta,et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.
[111] J. Buitelaar,et al. A Randomized, Double-Blind Study of Continuation Treatment for Attention-Deficit/Hyperactivity Disorder After 1 Year , 2007, Biological Psychiatry.
[112] J. Johnston,et al. Functional and psychosocial impairment in adults with undiagnosed ADHD , 2006, Psychological Medicine.
[113] A. Philipsen. Differential diagnosis and comorbidity of attention-deficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD) in adults , 2006, European Archives of Psychiatry and Clinical Neuroscience.
[114] W. Kim,et al. Child and Adolescent Psychiatry Workforce: A Critical Shortage and National Challenge , 2003, Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.
[115] Stephen P. Hinshaw,et al. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.
[116] J. Swanson. Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (Against). , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.
[117] J. Swanson,et al. Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long-Term? , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.
[118] Clarissa Tochetto de Oliveira. Psychoeducation for Attention De fi cit / Hyperactivity Disorder : What , How and Who Shall We Inform ? , 2018 .
[119] Alan E Kazdin,et al. Addressing the treatment gap: A key challenge for extending evidence-based psychosocial interventions. , 2017, Behaviour research and therapy.
[120] C. Whittington,et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis. , 2016, Health technology assessment.
[121] D. Cohen. Medication for attention deficit-hyperactivity disorder and criminality. , 2013, The New England journal of medicine.
[122] G. DuPaul,et al. TREATMENT OF ADHD IN SCHOOL SETTINGS , 2009 .
[123] R. Barkley,et al. The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology. , 1991, Journal of child psychology and psychiatry, and allied disciplines.